Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a transaction on July 10, 2012, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, the following acquisitions occurred at a price of 1,466.93 pence per Ordinary Share:
- Acquisition of 2 Ordinary Shares under the personal contribution element.
- Acquisition of 2 Ordinary Shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: July 10, 2012.
- Share Price: 1,466.93 pence per Ordinary Share.
- Parties Involved: Mr. P C Thomson (Director/PDMR) and Mrs. K Thomson (Connected Person).
- Total Shares Acquired: 4 Ordinary Shares (2 personal, 2 company match).
- Notification Date: July 11, 2012.